Maytree Asset Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,828
Closed -$38.7K 24
2025
Q4
$38.7K Hold
17,828
0.03% 16
2025
Q3
$98.2K Hold
17,828
0.09% 11
2025
Q2
$134K Hold
17,828
0.22% 11
2025
Q1
$117K Hold
17,828
0.21% 15
2024
Q4
$235K Hold
17,828
0.53% 14
2024
Q3
$101K Hold
17,828
0.2% 9
2024
Q2
$105K Sell
17,828
-1
-0% -$9 0.11% 25
2024
Q1
$161K Hold
17,829
0.3% 17
2023
Q4
$196K Hold
17,829
0.25% 33
2023
Q3
$316K Hold
17,829
0.4% 10
2023
Q2
$979K Hold
17,829
0.99% 11
2023
Q1
$1.21M Hold
17,829
1.3% 13
2022
Q4
$1.08M Hold
17,829
2.08% 8
2022
Q3
$1.79M Hold
17,829
1.33% 19
2022
Q2
$1.57M Hold
17,829
1.83% 16
2022
Q1
$2.71M Sell
17,829
-1,996
-10% -$371K 2.99% 12
2021
Q4
$6.32M Buy
+19,825
New +$6.99M 8.28% 5

Other funds holding RBOT

Maytree Asset Management's RBOT Position: Q1 2026 in Review

Maytree Asset Management sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 17,828 shares — an estimated $38.7K sold.

Maytree Asset Management first reported a position in RBOT in Q4 2021 and held it in 17 quarters. The position peaked at $6.32M in Q4 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Maytree Asset Management reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Maytree Asset Management sold 17,828 Vicarious Surgical shares in Q1 2026, an estimated $38.7K.
  • Maytree Asset Management first reported a position in Vicarious Surgical in Q4 2021 and held it in 17 quarters.
  • Maytree Asset Management's Vicarious Surgical position peaked at $6.32M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Maytree Asset Management's 13F filing for Q1 2026, filed 4 May 2026.